Figure S1. PD-L1 Expression is Not Quantitatively Altered on the Anti-Pd-1 Resistant Tumor Cells. from Suppression of Type I IFN Signaling in Tumors Mediates Resistance to Anti-PD-1 Treatment That Can Be Overcome by Radiotherapy